VaxGen Gets OK to Test Anthrax Vaccine
- Share via
From Bloomberg News
VaxGen Inc., which is developing vaccines for AIDS and smallpox, said it won Food and Drug Administration approval to begin testing a treatment to prevent anthrax.
Testing for the anthrax vaccine on about 100 volunteers will begin in June, a company spokesman said.
Shares of Brisbane, Calif.-based VaxGen rose 20 cents to $3.34 on Nasdaq.
The vaccine will be tested at Houston’s Baylor College of Medicine, Atlanta’s Emory University, Baltimore’s Johns Hopkins University and Saint Louis University Health Sciences Center.
